Marshall Wace North America’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $398K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $12.2M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $10.3M | Buy |
|
|||||
|
2020
Q1 | $444K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $10.1M | Buy |
|
|||||
|
2019
Q2 | $5.63M | Sell |
|
|||||
|
2019
Q1 | $17.8M | Buy |
|
|||||
|
2018
Q4 | $245K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $5.71M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $5.91M | Buy |
|
|||||
|
2017
Q2 | $685K | Sell |
|
|||||
|
2017
Q1 | $1.76M | Buy |
|